Cargando…
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
We previously reported that aberrant HH pathway activation confers a poor prognosis in rhabdomyosarcoma (RMS). Searching for new treatment strategies we therefore targeted HH signaling. Here, we identify a novel synthetic lethality of concomitant inhibition of HH and PI3K/AKT/mTOR pathways in RMS by...
Autores principales: | Graab, Ulrike, Hahn, Heidi, Fulda, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496179/ https://www.ncbi.nlm.nih.gov/pubmed/25749378 |
Ejemplares similares
-
Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
por: Schott, Christina, et al.
Publicado: (2015) -
PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells
por: Marklein, Diana, et al.
Publicado: (2012) -
Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines
por: Ridzewski, Rosalie, et al.
Publicado: (2015) -
Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors
por: Geyer, Natalie, et al.
Publicado: (2018) -
Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma
por: Eichenmüller, M, et al.
Publicado: (2010)